AI assistant
Cytosorbents Corp — Director's Dealing 2014
May 21, 2014
34501_dirs_2014-05-21_c9ed92b9-56bc-4aac-91fe-9c49500a7389.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2014-05-20
Reporting Person: BLOCH KATHLEEN P. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-20 | Common Stock | P | 110000 | $0.2355 | Acquired | 110000 | Indirect |
Footnotes
F1: The price in column 4 is a weighted average price. The prices actually paid by the reporting person's husband in this transaction range from $0.23 to $0.2355.
F2: The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range reported.
F3: The shares were purchased by the reporting person's husband, and as such, the reporting person may be deemed the beneficial owner of such shares.